INBRX-109
Ph1 INBRX-109
Phase 1 small_molecule active
Quick answer
INBRX-109 for Ewing Sarcoma is a Phase 1 program (small_molecule) at Inhibrx Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibrx Biosciences
- Indication
- Ewing Sarcoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active